Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Acetylcholine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 known ✓ | P20309 | 8/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 8/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 7/20 | 1.00 |
| ▸ | CHRM4 | P08173 | 7/20 | 1.00 |
| ▸ | CHRM5 | P08912 | 6/20 | 1.00 |
| ▸ | CHRNB2 | P17787 | 4/20 | 1.00 |
| ▸ | CHRNA4 | P43681 | 4/20 | 1.00 |
| ▸ | CHRNA7 | P36544 | 3/20 | 1.00 |
| ▸ | HTR1A | P08908 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | PGR | P06401 | 1/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 1/20 | 1.00 |
| ▸ | CHRNB4 | P30926 | 1/20 | 1.00 |
| ▸ | CHRNA3 | P32297 | 1/20 | 1.00 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 1.00 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 1.00 |
| ▸ | GALR3 | O60755 | 2/20 | 0.95 |
| ▸ | GAA | P10253 | 1/20 | 0.95 |
| ▸ | RAB9A | P51151 | 1/20 | 0.95 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetylcholine SCHEMBL2518957 | 1.00 | CHRM1 (1.00) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Acetylcholine SCHEMBL15687718 | 0.97 | CHRM1 (0.95) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Acetylcholine SCHEMBL21925712 | 0.97 | CHRM1 (0.95) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Acetylcholine SCHEMBL1157050 | 0.97 | CHRM1 (0.95) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Acetylcholine SCHEMBL6023859 | 0.97 | CHRM1 (0.95) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Acetylcholine SCHEMBL1899186 | 0.97 | CHRM1 (0.95) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Acetylcholine SCHEMBL18227923 | 0.97 | CHRM1 (0.95) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Acetylcholine SCHEMBL8513991 | 0.97 | CHRM1 (0.95) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Acetylcholine SCHEMBL3904052 | 0.97 | CHRM1 (0.95) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Acetylcholine SCHEMBL40885 | 0.97 | CHRM5 (1.00) | CHRM1CHRM3CHRM2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 137784 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4746864-A1 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR TREATING METABOLIC DYSFUNCTION | Keto Innovations, LLC (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122082046-A | Method for selectively separating valuable metals from waste lithium battery anode material | — | 2026-05-26 | — | — | CN | claimed |
| CN-122082124-A | Semiconductor surface treating agent and application thereof, and silicon carbide laser modified layer stripping method | — | 2026-05-26 | — | — | CN | claimed |
| CN-122094729-A | Method and device for detecting ventilation of myasthenia patient based on detection | — | 2026-05-26 | — | — | CN | claimed |
| CN-122084582-A | Auxiliary kit for detecting content of calcium ions in cells | — | 2026-05-26 | — | — | CN | claimed |
| US-12636476-B2 | Method of implantation of cell aggregates and tissue fragments | NEURONANO AB (SE) | 2026-05-26 | — | — | US | claimed |
| US-12638459-B2 | Method of diagnosing overactive bladder disorder | UNIVERSITY OF PORTSMOUTH HIGHER EDUCATION CORPORATION (GB) | 2026-05-26 | — | — | US | claimed |
| US-12635684-B2 | Methods and compositions for biopreservation | THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE (US) | 2026-05-26 | — | — | US | claimed |
| WO-2026104987-A1 | REMIBRUTINIB FOR USE IN THE TREATMENT OF MYASTHENIA GRAVIS | NOVARTIS AG (CH) | 2026-05-21 | — | — | WO | claimed |
| US-4241180-A | Enzymatic method for determining surfactants on surfaces | OWENS-ILLINOIS, INC. (US) | 1980-12-23 | — | — | US | claimed |
| WO-1980002111-A1 | PROCESS AND COMPOSITION FOR TREATING DISORDERS BY ADMINISTERING LECITHIN | MASSACHUSETTS INST TECHNOLOGY (US) | 1980-10-16 | — | — | WO | claimed |
| US-4221784-A | Process and composition for treating disorders by administering lecithin | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1980-09-09 | — | — | US | claimed |
| EP-0012819-A2 | Method for forming a film adhering to a substrate and method for writing and erasing information in a film thus prepared | International Business Machines Corporation (US) | 1980-07-09 | — | — | EP | claimed |
| US-4202875-A | FOR DIAGNOSIS OF MYASTHENIA GRAVIS | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1980-05-13 | — | — | US | claimed |
| US-RE30059-E | Assay for myasthenia gravis | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1979-07-31 | — | — | US | claimed |
| EP-0001924-A1 | Pharmaceutical composition for administering choline | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1979-05-16 | — | — | EP | claimed |
| US-4104397-A | TREATMENT OF ACETYLCHOLINE DEFICIENCY | THE PURDUE FREDERICK COMPANY (US) | 1978-08-01 | — | — | US | claimed |
| US-4078049-A | Acetylcholine assay | HOFFMANN-LA ROCHE INC. (US) | 1978-03-07 | — | — | US | claimed |
| US-4033722-A | IMMUNOLOGY, LABELS, RADIOACTIVE MATERIALS | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1977-07-05 | — | — | US | claimed |